Skip to main content

Want a detailed portfolio tracker?

enGene (ENGN) P/E (2023 - 2026)

enGene (ENGN) P/E from Nov 1, 2023 to Jun 3, 2026. The TTM enGene (ENGN) P/E is -0.74. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of enGene (ENGN)

YearP/EChange
2026-0.74-81.19%
2025-3.95-15.51%
2024-4.68+80.31%
2023-2.60N/A

Comparison enGene (ENGN) P/E with competitors

enGene (ENGN) P/E is -0.74.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.23%
NBYStablecoin Development Corp0.10-113.74%
FGENFibroGen Inc0.24-132.27%
TRAWTraws Pharma Inc0.47-163.56%
FBIOFortress Biotech Inc0.71-194.91%
CHRSCoherus Biosciences Inc0.98-231.48%
ORMPOramed Pharmaceuticals Inc1.47-298.06%
AGENAgenus Inc2.05-375.36%
VIVSVivoSim Labs Inc2.54-440.87%
INVAInnoviva Inc3.19-528.61%
CRMDCorMedix Inc3.65-590.07%
ABEOAbeona Therapeutics Inc4.20-665.25%
VXRTVaxart Inc4.26-672.86%
CVACCureVac N.V.4.45-697.60%
SRPTSarepta Therapeutics Inc4.62-721.60%
GLPGGalapagos NV4.86-753.14%
RIGLRigel Pharmaceuticals4.92-761.30%
ZVRAZevra Therapeutics Inc4.97-768.63%
ABUSArbutus Biopharma Corp5.69-865.37%
CGENCompugen Ltd7.38-1092.58%
AUPHAurinia Pharmaceuticals Inc9.25-1343.62%
ACADAcadia Pharmaceuticals Inc9.59-1388.87%
OMEROmeros Corporation9.88-1428.58%
PLXProtalix BioTherapeutics Inc9.91-1432.04%
SPROSpero Therapeutics Inc10.73-1543.02%
ADMAAdma Biologics Inc11.33-1623.13%
SVASinovac Biotech Ltd11.44-1637.29%
TBPHTheravance Biopharma Inc11.78-1683.08%
HRMYHarmony Biosciences Holdings Inc12.18-1737.36%
TGTXTG Therapeutics Inc13.18-1871.65%
INCYIncyte Corp13.38-1898.89%
SABSSAB Biotherapeutics Inc14.06-1989.72%
XOMAXOMA Corp14.95-2109.02%
REGNRegeneron Pharmaceuticals Inc14.98-2113.73%
PBYIPuma Biotechnology Inc15.05-2123.17%
EXELExelixis Inc15.79-2223.23%
NAGENiagen Bioscience Inc16.35-2298.53%
CPRXCatalyst Pharmaceuticals Inc17.34-2431.58%
MDXGMimedx Group Inc17.38-2435.70%
ARGXArgen X SE23.07-3201.42%
HALOHalozyme Therapeutics Inc23.20-3218.76%
XOMAOXOMA Corp25.34-3507.00%
VRTXVertex Pharmaceuticals Inc25.66-3548.81%
XOMAPXOMA Corp25.67-3550.73%
CTMXCytomX Therapeutics Inc25.70-3554.46%
ASNDAscendis Pharma A/S26.35-3642.68%
RPRXRoyalty Pharma plc - Class A27.50-3796.10%
SLNOSoleno Therapeutics Inc29.02-4000.41%
LGNDLigand Pharmaceuticals Inc - Class B30.19-4157.85%
BMRNBiomarin Pharmaceutical Inc37.51-5141.95%
APLSApellis Pharmaceuticals Inc39.02-5345.46%
KRYSKrystal Biotech Inc39.70-5436.39%
GMABGenmab40.20-5504.41%
ONCBeiGene Ltd67.03-9110.17%
TECHBio-Techne Corp68.59-9320.97%
VCELVericel Corp80.63-10938.67%
PHARPharming Group N.V.87.74-11894.57%
ALNYAlnylam Pharmaceuticals Inc124.93-16894.35%
TLXTelix Pharmaceuticals Ltd139.89-18904.97%
CORTCorcept Therapeutics Inc158.39-21391.66%